Target intelligence / Profile preview

Voltage-gated potassium channel subunit Kv3.2 (Kv3.2)

Target
Kv3.2
Molecular classification
Ion channel, Voltage-gated potassium channel, Tetrameric transmembrane protein
01

Overview

Voltage-gated potassium channel subunit Kv3.2 (encoded by KCNC2) is a tetrameric transmembrane protein forming potassium-selective pores in neuronal membranes. Kv3.2 channels are members of the Kv3 subfamily (including Kv3.1, Kv3.2, Kv3.3, Kv3.4), distinguished by their high activation threshold and rapid gating kinetics, enabling neurons to fire at very high rates (>100 Hz). These channels are strongly expressed in parvalbumin-positive interneurons, Purkinje cells, principal neurons of the auditory brainstem, and other fast-firing CNS cells. Kv3.2’s precise kinetics and gating properties are vital for maintaining rapid synaptic transmission, cortical inhibition, and neurologic functions underpinning learning, memory, and sensory processing. Disruption or mutation of Kv3.2—such as gain- or loss-of-function variants—can cause neurological diseases, most notably certain forms of epilepsy due to impaired GABAergic inhibition and developmental impairment. Molecularly, Kv3.2 channels are regulated by phosphorylation through kinases such as PKA and phosphatases like PP2A, affecting their open probability and current amplitude. Kv3.2 is a high-interest therapeutic target for interventions in epilepsy and possibly other brain disorders, though selectivity and safety remain ongoing challenges.

Other names
KCNC2Kv3.2 channelpotassium voltage-gated channel subfamily C member 2Kv3.2a
02

Mechanism of action

Blockade: Channel blockers (e.g., 4-aminopyridine) inhibit potassium efflux, prolonging action potentials. Allosteric modulation: Changes in phosphorylation state (PKA/PKG/PP2A) alter channel gating—enhancing or suppressing current. Disease-associated mutations (e.g., gain-of-function mutations Cys125Tyr) shift gating parameters and decrease firing rates of interneurons, leading to pathology like epilepsy.

03

Biological functions

Generation and repolarization of action potentialsEnables rapid, repetitive firing of neuronsRegulates synaptic transmission and neurotransmitter releaseMaintenance of membrane potential in fast-spiking interneurons
04

Disease associations

EpilepsyNeurodegenerative disease, including Parkinson’s and Alzheimer’s (modulatory; continued research)Developmental impairmentOther neurological disorders with disrupted high-frequency neuronal firing
05

Safety considerations

Non-selectivity of potassium channel blockers can lead to cardiac arrhythmias and muscle dysfunctionTherapeutic modulation risks disrupting critical neuronal firing needed for normal brain function, leading to cognitive or motor side effectsDisease-associated mutations may produce unpredictable “gain-of-function” or “loss-of-function” effects in neuronal circuits
06

Interacting drugs

4-aminopyridine

2 more in the full profile.

07

Biomarkers

KCNC2 gene mutation screening (epilepsy/neurodevelopmental disorders)Protein/phosphorylation status in relevant neuron subtypes (experimental; not clinical standard yet)

Beyond the preview

Go deeper on Voltage-gated potassium channel subunit Kv3.2 (Kv3.2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Voltage-gated potassium channel subunit Kv3.2 (Kv3.2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call